期刊文献+

抗人B7-H1单克隆抗体的制备和鉴定 被引量:1

Preparation and Identification of Anti-Human B7-H1 Monoclonal Antibody
下载PDF
导出
摘要 目的:采用杂交瘤技术制备抗人B7-H1单克隆抗体,并对其进行鉴定。方法:经抗原免疫的小鼠脾细胞与小鼠骨髓瘤细胞以常规方法融合;用间接ELISA法筛选分泌抗体的杂交瘤细胞株;阳性克隆用有限稀释法获得稳定分泌抗人B7-H1单克隆抗体的杂交瘤细胞株;扩增杂交瘤细胞注射进小鼠腹腔后制备腹水;纯化腹水中的单克隆抗体并对其亚型进行鉴定;用间接ELISA法测抗体效价;将肺癌组织制成石蜡切片,用抗人B7-H1抗体进行免疫组化染色。结果:获得1株稳定分泌抗人B7-H1单克隆抗体的杂交瘤细胞株,所分泌的单抗类型为IgG1;抗体效价为1×108,纯化后的抗体含量为6.76g/L;免疫组化实验中,单抗可与肺癌组织表面的B7-H1蛋白特异地结合。结论:制备了人B7-H1单克隆抗体,为B7-H1检测试剂盒的研制奠定了基础。 Objective: Preparation of anti-human B7-H1 monoclonal antibody with hybridoma technique and preliminary analysis of the application. Methods: The immunized mouse spleen cells and mouse myeloma cells were fused by routine method, indirect ELISA were used to screen the hybridoma. The positive clones were subcloned acquire hybridoma cells secreting anti-human B7-H1 monoclonal antibody. The amplified hybridoma cells were injected into abdominal cavity of mouse and the ascites were collected. The antibodies in the ascites were purified and titrated, and were indentified by immunohistochemical stain of lung cancer tissues. Results: One hybridoma cell line secreting anti-human B7-H1 monoclonal antibody was acquired. The subclass of the antibody was IgG1, the titer was 1×108, the concentration was 6.76 g / L after purification, and the antibody could combine with the B7-H1 which was on the surface of lung cancer tissues specifically. Conclusion: The anti-human B7-H1 monoclonal antibody was prepared successfully, which lay a foundation for later establishment of B7-H1 detecting kit
出处 《生物技术通讯》 CAS 2010年第4期531-534,共4页 Letters in Biotechnology
基金 国家自然科学基金(30801012)
关键词 人B7-H1 杂交瘤细胞 单克隆抗体 human B7-H1 hybridoma cells monoclonal antibody
  • 相关文献

参考文献6

  • 1Deng H,Zhu G,Tamada K,et al.B7-H1,the third member of the B7 family,co-stimulates T-cell proliferation and inter leukin-10 ascretion[J].Nat Med,1999,5:1365-1369.
  • 2Dong H,Strome S E,Salomao D R,et al.Tumor-associated B7-H1 promotes T-cell apoptosis:a potential mechanism of immune evasion[J].Nat Med,2002,8:793-800.
  • 3Blank C,Brown I,Peterson A C,et al.PD-L1/BTH-1 inhibits the effector phase of tumor rejection by T cell receptor(TCR)transgenic CD8+T cells[J].Cancer Res,2004,64:1140-1145.
  • 4Selenko-Gebauer N,Majdic O,Szekeras K,et al.BT-H1(programmed death-1 ligand)on dendritic cells is involved in the induction and maintenance of T cell anergy[J].J Immunol,2003,170:3637-3644.
  • 5Thompson R H,Kuntz S M,Leibovich B C,et al.Tumor B7H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up[J].Cancer Res,2006,66:3381-3385.
  • 6王伟华,张英起,颜真.重组B7-H1IgV融合蛋白的表达、纯化及活性鉴定[J].中国生物制品学杂志,2007,20(1):9-14. 被引量:5

二级参考文献1

共引文献4

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部